Global Pet Medication Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Pet Medication Product Introduction
• 1.2 Market Segments
• 1.3 Key Pet Medication Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Pet Medication Market Size Growth Rate by Type
  • 1.4.2 Antibiotics
  • 1.4.3 Antifungal
  • 1.4.4 Flea Products
• 1.5 Market by Application
  • 1.5.1 Global Pet Medication Market Size Growth Rate by Application
  • 1.5.2 Cat
  • 1.5.3 Dog
  • 1.5.4 Horse
  • 1.5.5 Fish
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Pet Medication Market Size, Estimates and Forecasts
  • 2.1.1 Global Pet Medication Revenue 2015-2026
  • 2.1.2 Global Pet Medication Sales 2015-2026
• 2.2 Global Pet Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Pet Medication Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Pet Medication Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pet Medication Competitor Landscape by Players

• 3.1 Pet Medication Sales by Manufacturers
  • 3.1.1 Pet Medication Sales by Manufacturers (2015-2020)
  • 3.1.2 Pet Medication Sales Market Share by Manufacturers (2015-2020)
• 3.2 Pet Medication Revenue by Manufacturers
  • 3.2.1 Pet Medication Revenue by Manufacturers (2015-2020)
  • 3.2.2 Pet Medication Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Pet Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Pet Medication Revenue in 2019
  • 3.2.5 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Pet Medication Price by Manufacturers
• 3.4 Pet Medication Manufacturing Base Distribution, Product Types
  • 3.4.1 Pet Medication Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Pet Medication Product Type
  • 3.4.3 Date of International Manufacturers Enter into Pet Medication Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Pet Medication Market Size by Type (2015-2020)
  • 4.1.1 Global Pet Medication Sales by Type (2015-2020)
  • 4.1.2 Global Pet Medication Revenue by Type (2015-2020)
  • 4.1.3 Pet Medication Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Pet Medication Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Pet Medication Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Pet Medication Revenue Forecast by Type (2021-2026)
  • 4.2.3 Pet Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Pet Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Pet Medication Market Size by Application (2015-2020)
  • 5.1.1 Global Pet Medication Sales by Application (2015-2020)
  • 5.1.2 Global Pet Medication Revenue by Application (2015-2020)
  • 5.1.3 Pet Medication Price by Application (2015-2020)
• 5.2 Pet Medication Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Pet Medication Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Pet Medication Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Pet Medication Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Pet Medication by Country
  • 6.1.1 North America Pet Medication Sales by Country
  • 6.1.2 North America Pet Medication Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Pet Medication Market Facts & Figures by Type
• 6.3 North America Pet Medication Market Facts & Figures by Application

7 Europe

• 7.1 Europe Pet Medication by Country
  • 7.1.1 Europe Pet Medication Sales by Country
  • 7.1.2 Europe Pet Medication Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Pet Medication Market Facts & Figures by Type
• 7.3 Europe Pet Medication Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Pet Medication by Region
  • 8.1.1 Asia Pacific Pet Medication Sales by Region
  • 8.1.2 Asia Pacific Pet Medication Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Pet Medication Market Facts & Figures by Type
• 8.3 Asia Pacific Pet Medication Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Pet Medication by Country
  • 9.1.1 Latin America Pet Medication Sales by Country
  • 9.1.2 Latin America Pet Medication Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Pet Medication Market Facts & Figures by Type
• 9.3 Central & South America Pet Medication Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Pet Medication by Country
  • 10.1.1 Middle East and Africa Pet Medication Sales by Country
  • 10.1.2 Middle East and Africa Pet Medication Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Pet Medication Market Facts & Figures by Type
• 10.3 Middle East and Africa Pet Medication Market Facts & Figures by Application

11 Company Profiles

• 11.1 Zoetis
  • 11.1.1 Zoetis Corporation Information
  • 11.1.2 Zoetis Description and Business Overview
  • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Zoetis Pet Medication Products Offered
  • 11.1.5 Zoetis Related Developments
• 11.2 Merck
  • 11.2.1 Merck Corporation Information
  • 11.2.2 Merck Description and Business Overview
  • 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Merck Pet Medication Products Offered
  • 11.2.5 Merck Related Developments
• 11.3 Elanco
  • 11.3.1 Elanco Corporation Information
  • 11.3.2 Elanco Description and Business Overview
  • 11.3.3 Elanco Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Elanco Pet Medication Products Offered
  • 11.3.5 Elanco Related Developments
• 11.4 Bayer
  • 11.4.1 Bayer Corporation Information
  • 11.4.2 Bayer Description and Business Overview
  • 11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Bayer Pet Medication Products Offered
  • 11.4.5 Bayer Related Developments
• 11.5 Boehringer
  • 11.5.1 Boehringer Corporation Information
  • 11.5.2 Boehringer Description and Business Overview
  • 11.5.3 Boehringer Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Boehringer Pet Medication Products Offered
  • 11.5.5 Boehringer Related Developments
• 11.6 Novartis
  • 11.6.1 Novartis Corporation Information
  • 11.6.2 Novartis Description and Business Overview
  • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Novartis Pet Medication Products Offered
  • 11.6.5 Novartis Related Developments
• 11.7 Virbac
  • 11.7.1 Virbac Corporation Information
  • 11.7.2 Virbac Description and Business Overview
  • 11.7.3 Virbac Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Virbac Pet Medication Products Offered
  • 11.7.5 Virbac Related Developments
• 11.8 Ceva
  • 11.8.1 Ceva Corporation Information
  • 11.8.2 Ceva Description and Business Overview
  • 11.8.3 Ceva Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 Ceva Pet Medication Products Offered
  • 11.8.5 Ceva Related Developments
• 11.9 Vetoquinol
  • 11.9.1 Vetoquinol Corporation Information
  • 11.9.2 Vetoquinol Description and Business Overview
  • 11.9.3 Vetoquinol Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Vetoquinol Pet Medication Products Offered
  • 11.9.5 Vetoquinol Related Developments
• 11.10 Nexvet
  • 11.10.1 Nexvet Corporation Information
  • 11.10.2 Nexvet Description and Business Overview
  • 11.10.3 Nexvet Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 Nexvet Pet Medication Products Offered
  • 11.10.5 Nexvet Related Developments
• 11.1 Zoetis
  • 11.1.1 Zoetis Corporation Information
  • 11.1.2 Zoetis Description and Business Overview
  • 11.1.3 Zoetis Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Zoetis Pet Medication Products Offered
  • 11.1.5 Zoetis Related Developments
• 11.12 Kindred Biosciences
  • 11.12.1 Kindred Biosciences Corporation Information
  • 11.12.2 Kindred Biosciences Description and Business Overview
  • 11.12.3 Kindred Biosciences Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Kindred Biosciences Products Offered
  • 11.12.5 Kindred Biosciences Related Developments
• 11.13 Ambrx
  • 11.13.1 Ambrx Corporation Information
  • 11.13.2 Ambrx Description and Business Overview
  • 11.13.3 Ambrx Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Ambrx Products Offered
  • 11.13.5 Ambrx Related Developments
• 11.14 Entest Biomedical
  • 11.14.1 Entest Biomedical Corporation Information
  • 11.14.2 Entest Biomedical Description and Business Overview
  • 11.14.3 Entest Biomedical Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Entest Biomedical Products Offered
  • 11.14.5 Entest Biomedical Related Developments
• 11.15 Taconic Biosciences
  • 11.15.1 Taconic Biosciences Corporation Information
  • 11.15.2 Taconic Biosciences Description and Business Overview
  • 11.15.3 Taconic Biosciences Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Taconic Biosciences Products Offered
  • 11.15.5 Taconic Biosciences Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Pet Medication Market Estimates and Projections by Region
  • 12.1.1 Global Pet Medication Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Pet Medication Revenue Forecast by Regions 2021-2026
• 12.2 North America Pet Medication Market Size Forecast (2021-2026)
  • 12.2.1 North America: Pet Medication Sales Forecast (2021-2026)
  • 12.2.2 North America: Pet Medication Revenue Forecast (2021-2026)
  • 12.2.3 North America: Pet Medication Market Size Forecast by Country (2021-2026)
• 12.3 Europe Pet Medication Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Pet Medication Sales Forecast (2021-2026)
  • 12.3.2 Europe: Pet Medication Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Pet Medication Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Pet Medication Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Pet Medication Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Pet Medication Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Pet Medication Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Pet Medication Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Pet Medication Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Pet Medication Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Pet Medication Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Pet Medication Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Pet Medication Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Pet Medication Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Pet Medication Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Pet Medication Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Pet Medication Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details